Trump administration announces funding for PTSD research on ibogaineWIRED investigation examines Jensen Huang's comments on defining women's power in techWalmart launches early Black Friday promotions on select giftsMint Mobile offers $500 discount on select new phones for new customers signing up for a yearRussia and Iran criticize U.S. Caspian task force amid reports of joint sanction evasion effortsNewly elected US lawmakers pose for traditional group photo at Capitol ahead of 120th Congress openingUS existing home sales drop to lowest monthly level in yearsPro-Palestine philanthropist faces US extradition hearing in SpainLewisham Islamic Centre criticizes charity watchdog over warning on Palestine commentsSenegalese wrestlers succeed in beach wrestling at Dakar Youth OlympicsUS nonprofits file lawsuit seeking pause on advanced AI model trainingDemocrats convene in Denver to discuss party direction after midterm victoriesUS releases report on $12bn from Venezuelan oil, mineral resourcesPope Leo XIV urges Catholic Church to address clergy sexual abuseShooting near White House results in death, suspect later found dead
All fact checks
AI analysis

Fact check

“Varda Space Industries has signed a deal with United Therapeutics to test whether drugs crystallize differently in microgravity.”
UnverifiableConfidence: LOW

Reasoning

The provided sources consistently describe a partnership between Varda Space Industries and United Therapeutics aimed at investigating drug crystallization in microgravity. No evidence contradicts this claim.

On confidence: Multiple independent excerpts from MIT Technology Review explicitly state that Varda Space Industries has signed a deal with United Therapeutics to test whether drugs crystallize differently in microgravity.

Important context

The deal's specific terms and the exact drugs to be studied were not disclosed, but the existence of the collaboration and its purpose are clearly reported.

Evidence

Supporting (3)

Contextual (1)

Limitations

The evidence is limited to press coverage; internal contract details are not publicly available, but the claim about the existence and purpose of the deal is well supported. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.

Last verified:
Sep 30, 2026, 7:38 PM CDT
Pipeline:
2.1.0
Claim type:
Factual

Where this claim appeared

The Download: climate tech companies to watch and AI’s discovery problem

MIT Technology Review · Thomas Macaulay